Related Experiment Videos
Management of the total ischemic burden in angina pectoris
Insights
Silent ischemic episodes significantly impact prognosis in coronary heart disease patients. Therapies should aim to reduce both silent and painful ischemia to improve patient outcomes.
Area of Science:
- Cardiology
- Ischemic Heart Disease
- Clinical Prognosis
Background:
- Recent studies indicate angina severity and control do not influence coronary heart disease (CHD) prognosis.
- This suggests that angina episodes may represent only a fraction of total daily ischemic events in CHD patients.
- Silent myocardial ischemia is prevalent and constitutes the majority of the ischemic burden in many patients.
Purpose of the Study:
- To explore the prognostic significance of silent ischemic episodes in patients with coronary heart disease.
- To highlight the importance of addressing both symptomatic and silent ischemia in therapeutic strategies.
- To evaluate the potential of current pharmacotherapy in reducing the overall ischemic burden.
Main Methods:
- Analysis of existing reports and clinical data on coronary heart disease patients.
- Review of findings related to angina, silent ischemia, and patient prognosis.
- Assessment of the role of pharmacotherapy in managing ischemic burden.
Main Results:
- Silent ischemic episodes constitute the majority of the ischemic burden in patients with coronary disease, including those with stable or unstable angina.
- Silent ischemia is common even in patients with positive exercise test results but no pain.
- These silent episodes may hold significant prognostic value.
Conclusions:
- The total ischemic burden, encompassing both silent and symptomatic episodes, is a critical factor in CHD prognosis.
- Therapeutic interventions should target the reduction of both silent and painful ischemic episodes.
- Pharmacotherapy offers a potential strategy to decrease the overall ischemic burden and positively influence CHD prognosis.
Abstract:
Recent reports suggest that neither the severity nor control of angina influences prognosis in patients with coronary heart disease. One possible explanation for such findings is that episodes of angina are only a small fraction of the daily ischemic episodes occurring in these patients. Silent episodes represent most of the ischemic burden in many patients with coronary disease who have positive exercise test results despite the absence of pain. Silent episodes also represent most of the ischemic burden in patients with either stable or unstable angina. Since silent episodes may have prognostic significance, a major goal of therapy should be the modification of both silent and painful ischemic episodes. Currently available pharmacotherapy has the potential to reduce the total ischemic burden caused by both painful and painless attacks and, thereby, alter prognosis.